Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Short term Debt (2016 - 2026)

Orthopediatrics has reported Short term Debt over the past 11 years, most recently at $2.0 million for Q1 2026.

  • For Q1 2026, Short term Debt rose 128.68% year-over-year to $2.0 million; the TTM value through Mar 2026 reached $2.0 million, up 128.68%, while the annual FY2025 figure was $1.7 million, 960.0% up from the prior year.
  • Short term Debt for Q1 2026 was $2.0 million at Orthopediatrics, up from $1.7 million in the prior quarter.
  • Over five years, Short term Debt peaked at $2.0 million in Q1 2026 and troughed at $139000.0 in Q1 2022.
  • A 5-year average of $464823.5 and a median of $154000.0 in 2024 define the central range for Short term Debt.
  • On a YoY basis, Short term Debt climbed as much as 960.0% in 2025 and fell as far as 73.4% in 2025.
  • Year by year, Short term Debt stood at $144000.0 in 2022, then rose by 5.56% to $152000.0 in 2023, then grew by 5.26% to $160000.0 in 2024, then soared by 960.0% to $1.7 million in 2025, then rose by 20.81% to $2.0 million in 2026.
  • Business Quant data shows Short term Debt for KIDS at $2.0 million in Q1 2026, $1.7 million in Q4 2025, and $166000.0 in Q3 2025.